[ALK, a key gene in the pathogenesis of neuroblastoma].
Janoueix-Lerosey
Isabelle
I
Delattre
Olivier
O
D000077548:Anaplastic Lymphoma Kinase; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D018450:Disease Progression; D005784:Gene Amplification; D018095:Germ-Line Mutation; D006801:Humans; D020125:Mutation, Missense; D009363:Neoplasm Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D009447:Neuroblastoma / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D010524:Peripheral Nervous System Neoplasms / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D017434:Protein Structure, Tertiary; D011505:Protein-Tyrosine Kinases / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D020794:Receptor Protein-Tyrosine Kinases; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology
D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases